STOCK TITAN

Insider Neil Kumar plans Rule 144 sale for BBIO (NASDAQ: BBIO) stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

BBIO insider Neil Kumar has filed a Rule 144 notice to sell 120,000 shares of common stock. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $8,912,400.00 based on the figures provided, and is listed against 192,708,813 common shares outstanding.

The 120,000 shares were acquired on 03/26/2016 through the conversion of management incentive units from the issuer, with no separate cash payment noted. The filing also discloses multiple recent Rule 10b5-1 sales over the past three months, including 30,011 shares sold for gross proceeds of $2,239,901.00 on 12/15/2025 for Neil Kumar, and 20,000-share sales by related revocable and irrevocable trusts on several November and December 2025 dates.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the BBIO Form 144 filing disclose?

The filing discloses that Neil Kumar, an insider associated with BBIO, has filed a Rule 144 notice to sell 120,000 shares of the company’s common stock through Morgan Stanley Smith Barney LLC on NASDAQ.

How many BBIO shares are planned to be sold under this Rule 144 notice?

The notice covers a proposed sale of 120,000 shares of BBIO common stock, with an indicated aggregate market value of $8,912,400.00.

When and how were the 120,000 BBIO shares originally acquired?

The 120,000 shares were acquired on 03/26/2016 via a Conversion of Management Incentive Units from the issuer, with the nature of payment listed as N/A.

How many BBIO shares are shown as outstanding in this filing?

The securities information section lists 192,708,813 BBIO common shares as outstanding.

What prior BBIO stock sales are disclosed for the past three months?

The filing lists multiple Rule 10b5-1 sales of BBIO common stock in the past three months, including 30,011 shares sold for $2,239,901.00 on 12/15/2025 for Neil Kumar and several 20,000-share sales by the Kumar Haldea revocable and family irrevocable trusts in October, November, and December 2025.

Which broker is handling the planned BBIO share sale under Rule 144?

The proposed sale of BBIO common stock is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

On which exchange are the BBIO shares to be sold according to the notice?

The notice identifies NASDAQ as the securities exchange on which the BBIO common shares are to be sold.

Bridgebio Pharma

NASDAQ:BBIO

BBIO Rankings

BBIO Latest News

BBIO Latest SEC Filings

BBIO Stock Data

14.70B
166.55M
4.77%
101.53%
10.41%
Biotechnology
Pharmaceutical Preparations
Link
United States
PALO ALTO